Results 191 to 200 of about 74,605 (231)
Some of the next articles are maybe not open access.

Related searches:

Radioimmunoassay of Glibenclamide

Diabetes, 1979
A specific, sensitive, and simple radioimmunoassay was developed for the oral hypoglycemic drug glibenclamide, N-4-[2-(5-chloro-2-methoxy-benzamide)- ethyl]-benzenesulfonyl-N'-cyclohexylurea. Antiserum against glibenclamide was obtained from rabbits immunized with an antigen prepared by conjugating the diazonium salt of N-(p-amino-benzamidoethyl ...
K, Kawashima, T, Kuzuya, A, Matsuda
openaire   +2 more sources

Radioimmunoassay for immunoconglutinins

Journal of Immunological Methods, 1980
A competitive radioimmunoassay for immunoconglutinin (IK) was developed using isolated antostimulated rabbit IK labelled with 125I and glutaraldehyde-fixed sheep erythrocytes coated with fixed complement (EAC). IKs in test sera of human or animal origin produced specific inhibition of uptake of [125I]IK onto EAC and this was quantitated by reference to
M, Druguet   +3 more
openaire   +2 more sources

Radioimmunoassay of ligandin

Gastroenterologia Japonica, 1979
A sensitive and specific radioimmunoassay for rat and human serum ligandin was developed using antisera generated in rabbits by the injection of ligandin purified from liver. Because rat ligandin and human ligandin have no cross reactivity, radioimmunoassay systems for each of the serum ligandins were prepared. Highly purified ligandin labeled with125I
Masanobu Tsuru, S. Murao
openaire   +2 more sources

MELATONIN RADIOIMMUNOASSAY

The Journal of Clinical Endocrinology & Metabolism, 1975
A radioimmunoassay for melatonin has been developed after the raising of anti-melatonin antibodies in rabbits.
J, Arendt, L, Paunier, P C, Sizonenko
openaire   +2 more sources

A radioimmunoassay for diphenylhydantoin

Clinica Chimica Acta, 1973
Abstract A radioimmunoassay for the anticonvulsant compound diphenylhydantoin (DPH) has been developed. Antisera were prepared by immunizing animals with a DPH-chicken γ-globulin conjugate. The assay depends on the capacity of unlabelled DPH to compete with a known amount of [14C]DPH for the antibody-binding sites. The assay can detect as little as 0.
R E, Tigelaar   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy